Aehr Test Systems (NASDAQ: AEHR) is a prominent player in the semiconductor industry, specializing in test and burn-in equipment. The company recently reported its Q1 2026 earnings, revealing an earnings per share (EPS) of $0.01, which aligned with market expectations. However, the revenue of $11 million fell short of the anticipated $13.7 million, raising concerns among investors.
Despite surpassing analysts' predictions of break-even earnings on $10.8 million in sales, Aehr's stock experienced a significant decline of 25.7% by the following morning. This drop is largely attributed to a 16% decrease in revenue compared to the previous year. The reported profit was a non-GAAP figure, while the GAAP earnings showed a loss of $0.07 per share, contrasting with last year's Q1 profit of $0.02 per share.
Aehr's bookings for the quarter were $11.4 million, indicating future revenue trends. The backlog as of August 29, 2025, was $15.5 million, with an effective backlog of $17.5 million, including bookings made after the quarter's end. This performance underscores the company's involvement in AI and data center-related semiconductor testing, highlighting a multi-year market opportunity.
Financially, Aehr Test Systems faces challenges, as reflected by a negative price-to-earnings ratio of -117.60 and a negative earnings yield of -0.85%. The enterprise value to operating cash flow ratio is -76.66, indicating potential issues with cash flow generation. However, the company maintains a low debt-to-equity ratio of 0.087 and a strong current ratio of 7.06, suggesting solid liquidity.
